Q3 2024 · 13F-HR
Knoll Capital Management, LLCholdings as filed
Filed 2024-11-14 · accession 0001104659-24-118986
$215.8M
Reported value
36
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03828A101 | APLT | Applied Therapeutics Inc | $47.4M | 22.0% | 5,574,687 | Common | SOLE |
| G11196105 | — | Biohaven Pharmactl Hldg Co L | $35.5M | 16.5% | 710,422 | Common | SOLE |
| 01438T106 | ALDX | Aldeyra Therapeutics Inc | $29.5M | 13.7% | 5,475,516 | Common | SOLE |
| 011532108 | AGI | Alamos Gold Inc | $8.8M | 4.09% | 41,000 | Common | SOLE |
| 05337M104 | — | Avadel Pharmaceuticals Plc | $7.9M | 3.65% | 600,000 | Common | SOLE |
| 78463V107 | GLD | SPDR Gold Trust | $7.8M | 3.60% | 32,000 | Common | SOLE |
| M40527109 | ENTX | Entera Bio Ltd | $7.4M | 3.42% | 3,881,879 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA | $7.2M | 3.33% | 551,738 | Common | SOLE |
| 02155H200 | ALT | Altimmune Inc | $6.9M | 3.19% | 1,121,524 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma | $5.8M | 2.67% | 200,000 | Common | SOLE |
| 811916105 | SA | SEABRIDGE GOLD INC | $5.3M | 2.47% | 317,003 | Common | SOLE |
| 67576A100 | OCUL | Ocular Therapeutix Inc. | $5.2M | 2.42% | 600,400 | Common | SOLE |
| G59665102 | MGTX | MeiraGTX Holdings | $5.2M | 2.42% | 1,250,000 | Common | SOLE |
| 008474108 | AEM | Agnico Eagle Mines Ltd | $4.5M | 2.07% | 55,500 | Common | SOLE |
| 496902404 | KGC | Kinross Gold Corp | $4.1M | 1.91% | 440,000 | Common | SOLE |
| 29446Y502 | EQX | Equinox Gold Corp | $3.4M | 1.55% | 550,811 | Common | SOLE |
| 351858105 | FNV | Franco Nev Corp | $3.1M | 1.44% | 25,000 | Common | SOLE |
| 83056P715 | SKE | SKEENA RES LTD CAD | $2.7M | 1.24% | 315,400 | Common | SOLE |
| 55903Q104 | MQ8 | Mag Silver Corp | $2.4M | 1.11% | 170,000 | Common | SOLE |
| 46428Q109 | SLV | iShares Silver Trust | $2.3M | 1.05% | 80,000 | Common | SOLE |
| 099502106 | BAH | Booz Allen Hamilton HLDG COR | $2.1M | 0.98% | 13,000 | Common | SOLE |
| 92826C839 | V | Visa | $1.3M | 0.62% | 4,850 | Common | SOLE |
| 718172109 | PM | Philip Morris Intl. Inc | $1.2M | 0.56% | 10,000 | Common | SOLE |
| 464288760 | ITA | iSHares US Aerospace & Defense | $1.1M | 0.53% | 7,650 | Common | SOLE |
| 666807102 | NOC | Northrop Grumman Corp | $1.1M | 0.53% | 2,165 | Common | SOLE |
| 589492107 | MREO | Mereo Biopharma Group | $1.1M | 0.50% | 260,470 | Common | SOLE |
| 780287108 | RGLD | Royal Gold Inc. | $1.1M | 0.49% | 7,550 | Common | SOLE |
| 25243Q205 | DEO | Diageo PLC | $947,295 | 0.44% | 6,750 | Common | SOLE |
| 126650100 | CVS | CVS Health Corp | $911,760 | 0.42% | 14,500 | Common | SOLE |
| 962879102 | WPM | Wheaton Precious Metals Corp | $763,500 | 0.35% | 12,500 | Common | SOLE |
| 64782A107 | NEWP | New Pac Metals Corp | $722,650 | 0.33% | 485,000 | Common | SOLE |
| 828363101 | SIL1EUR | Silvercrest Metals Inc CAD | $555,000 | 0.26% | 60,000 | Common | SOLE |
| 68619K105 | — | Orgenesis, Inc. | $283,089 | 0.13% | 63,473 | Common | SOLE |
| 14161Y200 | CRDL | Cardiol Therapeutics Inc | $198,000 | 0.09% | 100,000 | Common | SOLE |
| 67577R102 | IRD | Ocuphire Pharma Inc. | $131,000 | 0.06% | 100,000 | Common | SOLE |
| 384747101 | GRAL | Grail Inc | $1,376 | 0.00% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.